Literature DB >> 12488544

Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway.

Diana J Auyeung1, Fay K Kessler, Joseph K Ritter.   

Abstract

The utility of oltipraz as a cancer chemopreventive agent is thought to depend on the induction of enzymes involved in phase 2 xenobiotic detoxification. Although studies of some enzymes induced by oltipraz implicate a novel transcriptional activating pathway involving Nrf2 and antioxidant-response elements (AREs), the mechanism of phenol UGT induction has remained unclear. Previous work showed that UGT1A6 is transcribed from two promoters, P1 and P2, that are both induced by oltipraz in rat liver. The effect also occurs in rat hepatocytes treated with oltipraz (concentrations >3 microM). To investigate the mechanism, luciferase reporter plasmids under the control of P1 [p(-1078/+27)1A6P1-luc] or P2 [p(-1354/+65)1A6P2-luc] were transfected into rat hepatocytes and tested for inducibility. P1, but not P2, showed responsiveness to oltipraz (2- to 5-fold increase) and 3-methylcholanthrene (10- to 30-fold increase). Because P1 contained no visible AREs, the role of a xenobiotic response element (XRE) centered between bases -134 and -129 was evaluated. Mutation of the XRE core reduced the effects of both oltipraz and 3-methylcholanthrene on the P1 reporter. The 1A6 XRE conferred oltipraz responsiveness on the simian virus 40 promoter of pGL3-Promoter. Comparative effects of oltipraz and 3-methylcholanthrene on transfected cytochrome P4501A1 reporters support the general but relatively weak XRE-stimulating activity of oltipraz. The involvement of the aryl hydrocarbon receptor (AHR) and aryl hydrocarbon nuclear translocator (ARNT) in mediating the effects of oltipraz on the XRE is supported by electrophoretic mobility supershift data and AHR/ARNT overexpression studies. These data raise questions about the contribution of AHR and other secondary induction pathways in the mechanism of oltipraz.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12488544     DOI: 10.1124/mol.63.1.119

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

1.  Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.

Authors:  Shuhua Xu; Jittima Weerachayaphorn; Shi-Ying Cai; Carol J Soroka; James L Boyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-15       Impact factor: 4.052

2.  Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs.

Authors:  D P Jackson; A D Joshi; C J Elferink
Journal:  Toxicol Res (Camb)       Date:  2015-03-17       Impact factor: 3.524

3.  Transcriptional factor aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogene.

Authors:  Vincent Sauzeau; José M Carvajal-González; Adelaida S Riolobos; María A Sevilla; Mauricio Menacho-Márquez; Angel C Román; Antonio Abad; María J Montero; Pedro Fernández-Salguero; Xosé R Bustelo
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

4.  Stimulation of transcriptional expression of human UDP-glucuronosyltransferase 1A1 by dexamethasone.

Authors:  Masanobu Kanou; Toru Usui; Hisao Ueyama; Hiroshi Sato; Iwao Ohkubo; Takaharu Mizutani
Journal:  Mol Biol Rep       Date:  2004-09       Impact factor: 2.316

5.  Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2.

Authors:  David B Buckley; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2009-01-14       Impact factor: 3.922

6.  Persistent induction of hepatic and pulmonary phase II enzymes by 3-methylcholanthrene in rats.

Authors:  Sudha R Kondraganti; Weiwu Jiang; Anil K Jaiswal; Bhagavatula Moorthy
Journal:  Toxicol Sci       Date:  2008-01-17       Impact factor: 4.849

7.  Dioxin-induced fetal growth retardation: the role of a preceding attenuation in the circulating level of glucocorticoid.

Authors:  Yukiko Hattori; Tomoki Takeda; Misaki Fujii; Junki Taura; Yuji Ishii; Hideyuki Yamada
Journal:  Endocrine       Date:  2014-04-11       Impact factor: 3.633

8.  Introducing the "TCDD-inducible AhR-Nrf2 gene battery".

Authors:  Ronnie L Yeager; Scott A Reisman; Lauren M Aleksunes; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2009-05-27       Impact factor: 4.849

9.  Induction of human UGT1A1 by a complex of dexamethasone-GR dependent on proximal site and independent of PBREM.

Authors:  Takuya Kuno; Hiroshi Togawa; Takaharu Mizutani
Journal:  Mol Biol Rep       Date:  2007-05-26       Impact factor: 2.316

10.  Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups.

Authors:  David T Szabo; Vicki M Richardson; David G Ross; Janet J Diliberto; Prasada R S Kodavanti; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2008-10-31       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.